Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Anhui Jiahe Pharmaceutical is a key manufacturing subsidiary of Genor Biopharma (JHBP), serving as the group's primary industrialization base for biologics and pharmaceutical products. Located in Fuyang, Anhui, the company operates large-scale production facilities designed to meet international GMP standards for monoclonal antibodies and other therapeutic proteins. The facility supports the commercialization of Genor's pipeline, including its approved infliximab biosimilar and various late-stage oncology candidates. Anhui Jiahe plays a critical role in Genor's strategy to provide high-quality, affordable innovative drugs and biosimilars to the global market. Its operations encompass the production of active pharmaceutical ingredients (APIs), intermediates, and finished dosage forms.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Anhui Jiahe Pharmaceutical.